# A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder

> clinical trial · VERIFIED · 2026-06-26

Status: RECRUITING · Sponsor: Bristol-Myers Squibb · Condition: Bipolar-I Disorder With Mania or Mania With Mixed Features

- Company: Bristol-Myers Squibb
- Sector: biotech
- Primary source: https://clinicaltrials.gov/study/NCT06951698

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.